Lee Fairlie to Cost-Benefit Analysis
This is a "connection" page, showing publications Lee Fairlie has written about Cost-Benefit Analysis.
Connection Strength
0,060
-
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP). Trials. 2018 Dec 20; 19(1):693.
Score: 0,036
-
Cost and outcomes of paediatric antiretroviral treatment in South Africa. AIDS. 2013 Jan 14; 27(2):243-50.
Score: 0,024